1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
Institut CurieNot applicable NCT05475366 Registry history of NCT05475366 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1/2 | 1 | |
| Phase 2 | 7 | |
| Phase 2/3 | 1 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06195709 | ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic… | Breast Carcinoma | Recruiting | 2026-04-17 |
| NCT05439005 | Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the… | Breast Cancer | Recruiting | 2026-01-30 |
| Phase 2/3 | ||||
| NCT04681417 | Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management… | Retinoblastoma | Recruiting | 2025-11-28 |
| Phase 2 | ||||
| NCT06659705 | Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI) | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting | 2026-04-15 |
| NCT07193394 | Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer | Metastatic Breast Cancer ( HER2 Negative) | Recruiting | 2026-02-23 |
| NCT05955170 | Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic… | HER2-positive Breast Cancer | Recruiting | 2025-03-27 |
| NCT06175390 | Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer | Triple Negative Breast Cancer | Active, Not Recruiting | 2026-02-06 |
| NCT02870907 | Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE… | Retinoblastoma | Active, Not Recruiting | 2026-01-07 |
| NCT02866136 | Conservative Treatments of Retinoblastoma | Retinoblastoma | Active, Not Recruiting | 2025-11-24 |
| NCT07111117 | Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in… | Neuroblastoma | Not Yet Recruiting | 2025-09-03 |
| Phase 1/2 | ||||
| NCT04446962 | LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate… | Lymphoma, Large B-Cell, Diffuse | Active, Not Recruiting | 2025-09-25 |
| Not applicable | ||||
| NCT06439901 | Optimizing Bronchopulmonary Cancer Screening | Bronchopulmonary Disease | Recruiting | 2026-09-10 |
| NCT01689584 | COsegregation of VARiants in Panel of Genes | Gene Mutation-Related Cancer | Recruiting | 2026-09-01 |
| NCT06225505 | Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE) | Triple Negative Breast Cancer | Recruiting | 2026-07-23 |
| NCT07491380 | Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6… | Breast Cancer | Recruiting | 2026-07-23 |
| NCT05558644 | Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial… | Cancer | Recruiting | 2026-07-10 |
| NCT05441163 | ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and… | CANCER | Recruiting | 2026-07-09 |
| NCT05354765 | Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer… | Cancer | Recruiting | 2026-05-06 |
| NCT04731610 | Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy… | Thymoma Malignant Recurrent | Recruiting | 2026-04-20 |
| NCT05088395 | Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4 | Cancer | Recruiting | 2026-04-14 |
| NCT05781295 | Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in… | Children | Recruiting | 2026-02-20 |
| NCT03017573 | Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link… | Ovarian Cancer | Recruiting | 2026-02-03 |
| NCT06459791 | Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From… | Metastatic Breast Cancer | Recruiting | 2026-01-29 |
| NCT06349512 | 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer… | Triple Negative Breast Cancer | Recruiting | 2025-12-22 |
| NCT04790682 | LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small… | Metastatic Lung Cancer | Recruiting | 2025-09-18 |
Breast Cancer (12) · Triple-Negative Breast Cancer (5) · Lung Cancer (3) · Pancreatic Cancer (2) · Sarcoma (2) · Cervical Cancer (1) · DLBCL (1) · Head & Neck Cancer (1) · HER2-Positive Cancer (1) · Leukemia (1)